MBK Partners to acquire 99.5% of Medit for KRW 2.45tn
- Deal value
- $1.7bn
- Stake
- 99.5%
- Implied 100%
- $1.7bn
- Revenue
- $131m
- Op. income
- $71m
- Multiples
- EQV/EBIT 23.9xPSR 12.9x
Deal value ÷ stake (structure unconfirmed)
2021 연결 · DART-verified
2021 연결 · DART-verified
On implied equity value
DART 20220411002054
- Target
- Medit · Dental 3D intraoral scanners
- Buyer
- MBK Partners · FI
- Seller
- Unison Capital Korea, founder Jang Min-ho and related parties
- Structure
- —
- Announced
- Dec 29, 2022
- Closed
- —
- Stage
- Signed
Target
Medit, founded by Professor Chang Min-ho, makes 3D intraoral scanners for dentistry and was reported as the global No.1 with a 24% market share.
Deal rationale
Seller Unison Capital Korea bought 50%+1 share of Medit for about KRW 320bn (EV ~KRW 640bn) at end-2019 and ran a 2022 sale; after price talks with the GS-Carlyle consortium failed, MBK was named preferred bidder. Edaily reported MBK valued the digital shift in dentistry and Medit's earnings growth, funding about KRW 1tn from its Fund V with the rest in acquisition financing. Founder Chang and management reinvested for a 30% stake.
| Revenue | $131m |
| Operating income | $71m |
| EBITDA | — |
| Net income | — |
2021 연결 · DART-verified · 20220411002054
Press coverage
- 더팩트 (2022-12-31): “메디트 지분을 2조4600억 원에 매입하는 주식양수도계약(SPA)을 체결했다.”
- 서울경제 (2022-12-30): “매매가 2조 4500억 원에 계약이 체결됐다.”
- 이데일리 (2022-12-31): “매각 대금은 약 2조4000억으로 알려졌으며”
- 블로터 (2024-01-24): “매각가는 2조5000억원으로”
- 이데일리 (2023-12-18): “약 2조4250억원 규모”
- 딜사이트 (2022-09-10): “당시 유니슨캐피탈은 메디트의 밸류에이션을 약 6400억원으로 책정하고, 지분 50%+1주를 3200억원에 인수했다.”
This is a data entry summarising filings and press reports. Please check the original sources for the figures.